Can Rubicon Research sustain its impressive growth while facing US market risks?

October 9, 2025

Rubicon Research plans to raise ₹500 crore through a fresh issue for debt repayment and acquisitions, alongside an ₹877.5 crore offer for sale. The pharmaceutical company reported strong revenue and profit growth with margin expansion, boasting a higher RoNW than peers. However, high revenue concentration in the US and from top customers presents a risk.

More To Explore

Is the smallcap rally a trap? Only 37% of stocks are outperforming their benchmark

India’s recent smallcap surge indicates that less stock is outpacing the benchmark index, revealing a narrowing group of successful stocks boosting overall returns. Conversely, largecap

August 25, 2026

Bernstein cuts PFC, REC target prices as bank competition weighs on loan growth

Bernstein has retained an Outperform rating on Power Finance Corporation (PFC) and REC but cut its target prices and loan-growth estimates, citing stronger competition from

August 25, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003